Condensed Consolidated Statements of Operations and Comprehensive Earnings (Loss) (Unaudited) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
Income Statement [Abstract]
Operating revenues (net of contractual allowances)	$ 25,196	$ 26,303	$ 74,913	$ 76,500
Less provision for bad debts of Healthcare Facilities Segment	1,845	1,837	6,060	6,125
Net revenues	23,351	24,466	68,853	70,375
Costs and Expenses
Cost of goods sold	6,181	7,078	16,253	17,838
Salaries, wages and benefits	10,729	10,591	32,135	32,105
Provision for bad debts of Specialty Pharmacy Segment	65	75	188	170
Supplies	1,877	1,808	6,017	5,790
Purchased services	1,208	1,289	3,410	3,884
Other operating expenses	2,695	2,994	7,035	8,967
Rent and lease expense	343	366	1,020	1,079
Insurance settlement	0	0	(1,000)	0
EHR incentive payments	(64)	(43)	(64)	(1,258)
Depreciation and amortization	602	773	1,817	2,310
Operating Profit (Loss)	(285)	(465)	2,042	(510)
Other Income, (Expense):
Gain on sale of assets	13	18	13	18
Interest expense - net	(213)	(234)	(677)	(714)
Earnings (Loss) from Continuing Operations before income taxes	(485)	(681)	1,378	(1,206)
Income Tax Expense (Benefit)	(169)	(105)	816	(200)
Earnings (Loss) from Continuing Operations	(316)	(576)	562	(1,006)
Loss from Discontinued Operations, net of tax	(95)	(388)	(409)	(889)
Net Earnings (Loss)	(411)	(964)	153	(1,895)
Other comprehensive income	0	0	0	0
Comprehensive Earnings (Loss)	$ (411)	$ (964)	$ 153	$ (1,895)
Continuing Operations:
Basic	$ (0.03)	$ (0.06)	$ 0.06	$ (0.11)
Diluted	$ (0.03)	$ (0.06)	$ 0.06	$ (0.11)
Discontinued Operations:
Basic	$ (0.01)	$ (0.04)	$ (0.04)	$ (0.09)
Diluted	$ (0.01)	$ (0.04)	$ (0.04)	$ (0.09)
Net Earnings (Loss):
Basic	$ (0.04)	$ (0.10)	$ 0.02	$ (0.20)
Diluted	$ (0.04)	$ (0.10)	$ 0.02	$ (0.20)
Weighted-Average Common Shares Outstanding:
Basic	9,443	9,443	9,443	9,443
Diluted	9,443	9,443	9,481	9,443